Test Seeks to Evaluate Covid-19 Protective Immunity in the United States
Tru-Immune will measure and quantify the neutralizing capacity of antibodies against the novel coronavirus SARS-CoV-2.
Read MorePosted by Laurie Bonner | Jun 23, 2020 | Covid 19 |
Tru-Immune will measure and quantify the neutralizing capacity of antibodies against the novel coronavirus SARS-CoV-2.
Read MorePosted by Laurie Bonner | Jun 23, 2020 | Uncategorized |
The assay is authorized for use with upper respiratory specimens collected from individuals suspected by their healthcare provider to have covid-19.
Read MorePosted by Laurie Bonner | Jun 23, 2020 | Covid 19 |
Features of the kit include 1.5-hour testing time from preparation to finish, 94-sample capacity, and a limit of detection of 1.2 copies of SARS-CoV-2 RNA per µL.
Read MorePosted by Laurie Bonner | Jun 22, 2020 | Covid 19 |
A pipetting robot from Denmark is automating covid-19 testing processes in hospitals around Europe.
Read MorePosted by Laurie Bonner | Jun 22, 2020 | Covid 19 |
Covid-19 Diagnostics Evidence Accelerator is a multi-stakeholder collaborative project to advance the development of diagnostics.
Read More